Generic Brilinta

Common use

Brilinta (ticagrelor) is prescribed to reduce the risk of cardiovascular events in patients with acute coronary syndrome (ACS) or a history of myocardial infarction. It works by inhibiting platelet aggregation, preventing blood clots from forming in arteries.

Dosage and direction

Brilinta is usually taken orally twice daily, with or without food. Swallow tablets whole with water. The initial dose may be higher (loading dose) followed by a maintenance dose, as directed by a healthcare provider. Regular monitoring of heart and bleeding symptoms is recommended.

Precautions

Inform your doctor if you have a history of bleeding disorders, stroke, liver disease, or low blood pressure. Use caution with activities that increase the risk of injury, as Brilinta increases bleeding risk.

Contraindications

Do not use Brilinta if allergic to ticagrelor or any component of the tablet. It is contraindicated in patients with active pathological bleeding or a history of intracranial hemorrhage.

Possible side effect

Common side effects include shortness of breath, headache, dizziness, or minor bleeding. Serious side effects may include severe bleeding, allergic reactions, or heart rhythm changes. Seek medical attention if severe symptoms occur.

Drug interaction

Brilinta may interact with anticoagulants, NSAIDs, aspirin, or other medications that increase bleeding risk. Inform your doctor of all prescription drugs, over-the-counter products, and supplements you are taking.

Missed dose

If a dose is missed, take it as soon as you remember unless it is almost time for the next dose. Do not double the dose.

Overdose

Overdose may increase the risk of severe bleeding or cause dizziness. Seek immediate medical attention if overdose is suspected.

Storage

Store Brilinta at room temperature, away from heat, moisture, and light. Keep tablets in the original container and out of reach of children.

Disclaimer

We provide only general information about medications which does not cover all directions, possible drug integrations, or precautions. Information at the site cannot be used for self-treatment and self-diagnosis. Any specific instructions for a particular patient should be agreed with your health care adviser or doctor in charge of the case. We disclaim reliability of this information and mistakes it could contain. We are not responsible for any direct, indirect, special or other indirect damage as a result of any use of the information on this site and also for consequences of self-treatment.

Clinical Verification

Last Clinically Updated: August 15, 2026

Written By

Dr. Elena Vance, PharmD

Clinical Specialist in Neuropharmacology

Fact Checked By

Marcus Thorne, MS

Biomedical Data & FDA Label Verification

Medically Reviewed By

Dr. Arthur Campbell, MD

Board-Certified Psychiatrist (ABPN)